Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.854
+0.01
(+1.67%)
After-Hours: 20:00
Sunshine Biopharma Cash from Investing (Quarterly): -0.2692M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.2692M |
| September 30, 2023 | 0.0189M |
| June 30, 2023 | -0.2595M |
| March 31, 2023 | -0.1463M |
| December 31, 2022 | -14.62M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -0.0004M |
| September 30, 2020 | -0.0008M |
| June 30, 2020 | |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0009M |
| September 30, 2019 | -0.0014M |
| June 30, 2019 | -0.013M |
| March 31, 2019 | |
| December 31, 2018 | 0.0085M |
| September 30, 2018 | 0.0802M |
| June 30, 2018 | -0.0225M |
| March 31, 2018 | -0.0801M |
| December 31, 2017 | -0.084M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0223M |
| June 30, 2017 | -0.0223M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0011M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.0023M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.6233M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.62M
Minimum
Dec 2022
0.0189M
Maximum
Sep 2023
-1.092M
Average
-0.0008M
Median
Cash from Investing (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.057M |
| Acasti Pharma Inc | -6.554M |
| Aurinia Pharmaceuticals Inc | -6.257M |
| Edesa Biotech Inc | 0.00 |
| Xenon Pharmaceuticals Inc | -239.73M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.690M |
| Cash from Financing (Quarterly) | -0.0305M |
| Free Cash Flow | -9.563M |
| Free Cash Flow Per Share (Quarterly) | -12.57 |
| Free Cash Flow to Equity (Quarterly) | -2.993M |
| Free Cash Flow to Firm (Quarterly) | -2.993M |
| Free Cash Flow Yield | -4.70K% |